D
Sell
3/11/2016Downgrade
VG Life Sciences Inc. (VGLS) was downgraded to D from C on 3/11/2016 due to a substantial decline in the volatility index and total return index.
C
Hold
8/21/2015Upgraded
VG Life Sciences Inc. (VGLS) was upgraded to C from C- on 8/21/2015 due to an increase in the efficiency index, growth index and total return index. Total capital increased 57.54% from -$476.2 to -$750.2, and operating cash flow increased 44% from -$165 to -$237.6.
C
Hold
4/16/2015Downgrade
VG Life Sciences Inc. (VGLS) was downgraded to C- from C on 4/16/2015 due to a decline in the growth index, solvency index and total return index. Earnings per share declined from -$0.0367 to -$0.011, EBIT declined 32.21% from -$798.8 to -$541.5, and the quick ratio declined from 0.01 to 0.01.
C
Hold
11/14/2014Upgraded
VG Life Sciences Inc. (VGLS) was upgraded to C from D on 11/14/2014 due to a significant increase in the efficiency index, growth index and volatility index. Operating cash flow increased 51.6% from -$308.9 to -$468.3.
D
Sell
9/29/2014Downgrade
VG Life Sciences Inc. (VGLS) was downgraded to D from D+ on 9/29/2014 due to a decline in the total return index and growth index.
D
Sell
9/12/2014Upgraded
VG Life Sciences Inc. (VGLS) was upgraded to D+ from on 9/12/2014 due to a significant increase in the solvency index, volatility index and total return index. Debt to equity declined from -0.53 to -0.52.
